By Roy Strom | May 7, 2018
After selling their litigation funding business to Burford Capital Ltd., the founders of Gerchen Keller Capital launched their own plaintiffs firm earlier this year. Now that new firm is taking aim at its first defendants.
By Charles Toutant | May 3, 2018
Litigation over generic drug applications under the Abbreviated New Drug Application process increased 30 percent in 2017, according to a report by litigation analytics company Lex Machina.
By Charles Toutant | April 6, 2018
In the nation's first trial where a jury linked Johnson & Johnson's talc products to mesothelioma, the company's efforts to discredit the plaintiffs' evidence simply fell flat.
Delaware Business Court Insider | News
By Tom McParland | March 29, 2018
A Delaware federal judge on Wednesday wiped out a $235 million verdict against Teva Pharmaceuticals for supposedly infringing a GlaxoSmithKline plc patent for the hypertension drug Coreg.
The American Lawyer | Analysis
By Miriam Rozen | March 28, 2018
The market is primed for another year of booming M&A action, but the art of the deal could be complicated by President Trump's temperamental tendencies.
By Amanda Bronstad | March 7, 2018
U.S. District Judge Dan Polster in Cleveland told lawyers in the multidistrict litigation to come up with a plan by March 16 over the scope and timing of a “litigation track.”
By Max Mitchell | February 27, 2018
Sessions outlined plans to create a new litigation-oriented task force within the Department of Justice to pursue claims against opioid manufacturers and distributors.
Delaware Business Court Insider | News
By Tom McParland | February 20, 2018
A Delaware federal judge on Feb. 16 overturned a massive $2.5 billion jury verdict against Gilead Sciences Inc., finding that a patent held by a unit of Merck & Co. Inc. was too broad to be valid.
By Sue Reisinger | January 25, 2018
The global general counsel job will move from Philadelphia, where Troy is based, to the United Kingdom, where the company has its headquarters.
By Amanda Bronstad | January 8, 2018
Lawyers who scored verdicts of $140 million and $150 million last year in the first trials over low testosterone medications have switched lead counsel for a trial that begins on Monday.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS